Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis

Kevin Damman1, Mattia A E Valente, Adriaan A Voors

  • 1University of Groningen, Department of Cardiology, University Medical Center Groningen, Hanzeplein 1, 9700RB, Groningen, The Netherlands.

European Heart Journal
|October 30, 2013
PubMed

Insights

Chronic kidney disease (CKD) and worsening renal function (WRF) are common in heart failure (HF) patients. Both conditions significantly increase mortality risk, highlighting the need for careful management in HF care.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Chronic kidney disease (CKD) and worsening renal function (WRF) are recognized complications in patients with heart failure (HF).
  • These conditions are independently associated with adverse outcomes, including increased mortality.

Purpose of the Study:

  • To systematically review the prevalence and prognostic impact of CKD and WRF in patients with HF.
  • To identify predictors of WRF in the HF population.

Main Methods:

  • A comprehensive literature search was conducted using MEDLINE and Cochrane databases.
  • Meta-analysis of 57 studies (1,076,104 patients) for CKD and 28 studies (49,890 patients) for WRF.
  • Secondary analysis focused on identifying predictors of WRF.

Main Results:

  • CKD prevalence was 32%, associated with a 2.34-fold increased odds of all-cause mortality.
  • WRF was present in 23% of patients, linked to a 1.81-fold increased risk of unfavorable outcomes.
  • Moderate/severe renal impairment and WRF were independent predictors of mortality (HRs ranging from 1.59 to 2.17).

Conclusions:

  • CKD and WRF are highly prevalent in HF patients and significantly elevate mortality risk.
  • Baseline CKD, hypertension, diabetes, age, and diuretic use predict WRF, indicating a poorer prognosis.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
2.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
642
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
807